Nymox Pharmaceutical
NYMX
#9607
Rank
ยฃ14.12 M
Marketcap
Country
ยฃ0.15
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Nymox Pharmaceutical (NYMX)

Revenue in 2023 (TTM): N/A

In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nymox Pharmaceutical from 1997 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) N/A
2022 N/A
2021 N/A-100%
2020 ยฃ0 M-95.82%
2019 ยฃ0.08 M-62.77%
2018 ยฃ0.23 M42.12%
2017 ยฃ0.16 M-27.89%
2016 ยฃ0.22 M-87.66%
2015 ยฃ1.86 M-1.65%
2014 ยฃ1.89 M-6.97%
2013 ยฃ2.03 M7.12%
2012 ยฃ1.9 M-5.11%
2011 ยฃ2 M346.5%
2010 ยฃ0.44 M74.54%
2009 ยฃ0.25 M-12.04%
2008 ยฃ0.29 M33.93%
2007 ยฃ0.21 M-2.91%
2006 ยฃ0.22 M-9.16%
2005 ยฃ0.24 M47.44%
2004 ยฃ0.16 M49.72%
2003 ยฃ0.11 M-49.76%
2002 ยฃ0.22 M37.61%
2001 ยฃ0.16 M7.2%
2000 ยฃ0.15 M-30.72%
1999 ยฃ0.21 M20.78%
1998 ยฃ0.18 M-1.09%
1997 ยฃ0.18 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ31.52 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ43.06 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.38 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ30.12 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ67.87 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA